Description
The Pharmacogenomics Panel is designed to help individuals understand how their unique genetic makeup may influence medication effectiveness, dosing requirements, and risk of side effects—based on actionable pharmacogenomic guidance identified by the FDA and clinical guidelines.
This test analyzes key genes involved in drug metabolism, transport, and response, providing personalized insights to support safer and more effective medication decisions.
Benefits
- Reduces trial-and-error prescribing by moving beyond one-size-fits-all medication guidelines
- Supports individualized drug selection and dosing based on genetic metabolism patterns
- Decreases risk of adverse drug reactions by identifying medications that may require dose adjustment or avoidance
- Improves medication efficacy by identifying drugs more likely to be effective
- Helps reduce overall healthcare costs by minimizing medication toxicity, side effects, and treatment failures
Clinical Areas Covered
This panel provides guidance and commentary across multiple therapeutic areas, including:
- Behavioral Health
- Cardiology
- Gastroenterology
- Neurology
- Pain Management
- Transplant Medicine
- Urology
What’s Included
- Actionable pharmacogenomic analysis across 44 medication classes
- Evaluation of 70 clinically relevant genes involved in drug metabolism and response
- Evidence-based insights to support medication selection, dosing, and safety
- Clear, patient-friendly reporting suitable for review with a healthcare provider
Who This Test Is For
- Individuals currently taking prescription medications
- Patients with medication side effects or poor treatment response
- Those starting new long-term medications
- Providers seeking data-driven support for medication decisions
